Skip to main content

PUBLIC
BILL SUMMARY For SB22-173

HOUSE COMMITTEE ON PUBLIC & BEHAVIORAL HEALTH & HUMAN SERVICES
Date May 3, 2022       Location HCR 0112

SB22-173 - Committee Discussion Only


02:47:45 PM  
Representative Bird and Representative McKean, co-prime bill sponsors, presented Senate Bill 22-173, concerning criteria relating to the operation of telepharmacy outlets.  Under current law, a telepharmacy outlet must be located more than 20 miles from any pharmacy or telepharmacy outlet. The bill removes this geographic restriction, and requires that a telepharmacy be located in an area of need, as defined under the bill. The State Board of Pharmacy is required to adopt rules concerning matters related to telepharmacy outlets.  
 
The bill sponsors responded to questions from the committee.
02:53:48 PM  
Tom Davis, representing RxPlus Pharmacies, testified in opposition to the bill.

Ky Davis, representing Harris Pharmacy, testified in opposition to the bill.

Dr. Maimuna Bruce, representing Telepharm, testified in support of the bill.

Dr. Jessica Adams, representing Telepharm, testified in support of the bill.

The panelists responded to questions from the committee.
03:06:31 PM  
Representative McKean and Representative Bird explained amendment L.008 (Attachment A).  Representative Bird referenced amendment L.009 (Attachment B). The bill sponsors responded to questions from the committee.

Mr. Ky Davis responded to additional questions from the committee.

Committee discussion with the bill sponsors ensued.

Dr. Bruce responded to additional questions from the committee.

The bill sponsors responded to additional questions from the committee.

03:24:53 PM  
The committee recessed.
03:25:34 PM  
The committee came back to order.  Representative Sirota laid over Senate Bill 22-173 until later in the calendar.